Lemaitre Vascular (LMAT) Return on Capital Employed (2011 - 2026)
Lemaitre Vascular's (LMAT) quarterly Return on Capital Employed came in at 12.4% in Q1 2026, up 238.0% year-on-year from 3.67% in Q1 2025, and up 4.17% on a QoQ basis from 11.9% in Q4 2025.
Lemaitre Vascular (LMAT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 16 years of Return on Capital Employed data on file, last reported at 12.4% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 238.0% year-over-year to 12.4% in Q1 2026; TTM through Mar 2026 was 12.4%, a 238.0% increase from a year earlier, with the FY2025 full-year figure at 12.41%, down 8.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 12.4%, up from 11.9% in the prior quarter.
- Over the last five years, Return on Capital Employed for LMAT reached as high as 14.56% in Q3 2024 and fell as low as 9.27% in Q1 2023.
- Historically, Return on Capital Employed has averaged 11.5% across 5 years, with a median of 11.41% in 2022.
- Across the five-year window, Return on Capital Employed plunged 572 bps in 2022 and surged 345 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 9.55% in 2022, then rose by 24 bps to 11.82% in 2023, then climbed by 2 bps to 12.05% in 2024, then slipped by 1 bps to 11.9% in 2025, then rose by 4 bps to 12.4% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 12.4% in Q1 2026, 11.9% in Q4 2025, and 11.17% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | 12.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.40% |
| Dec 31, 2025 | 11.90% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | 10.22% |
| Mar 31, 2025 | 10.02% |
| Dec 31, 2024 | 12.05% |
| Sep 30, 2024 | 14.56% |
| Jun 30, 2024 | 13.70% |
| Mar 31, 2024 | 12.58% |
| Dec 31, 2023 | 11.82% |
| Sep 30, 2023 | 11.11% |
| Jun 30, 2023 | 10.33% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 9.55% |
| Sep 30, 2022 | 10.16% |
| Jun 30, 2022 | 11.41% |
| Mar 31, 2022 | 13.27% |
| Dec 31, 2021 | 13.52% |
| Sep 30, 2021 | 15.32% |
| Jun 30, 2021 | 17.13% |